Methylprednisolone description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Methylprednisolone

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

METHYLPREDNISOLONE DESCRIPTION



Methylprednisolone




CLINICAL PHARMACOLOGY




INDICATIONS & USAGE


1.Endocrine Disorders




2.Rheumatic Disorders










3.Collagen Diseases



4.Dermatologic Diseases







5.Allergic States







6.Ophthalmic Diseases










7.Respiratory Diseases





8.Hematologic Disorders





9.Neoplastic Diseases



10.Edematous States

11.Gastrointestinal Diseases



12.Nervous System

13.Miscellaneous



METHYLPREDNISOLONE CONTRAINDICATIONS



WARNINGS




Usage in pregnancy:

While on corticosteroid therapy patients should not be vaccinated against smallpox. Other immunization procedures should not be undertaken in patients who are on corticosteroids, especially on high dose, because of possible hazards of neurological complications and a lack of antibody response.




PRECAUTIONS

General Precautions









DOSAGE AND ADMINISTRATION




INFORMATION FOR PATIENTS



METHYLPREDNISOLONE ADVERSE REACTIONS

Fluid and Electrolyte Disturbances






Musculoskeletal







Gastrointestinal




Dermatologic






Neurological




Endocrine







Ophthalmic




Metabolic




DOSAGE & ADMINISTRATION


IT SHOULD BE EMPHASIZED THAT DOSAGE REQUIREMENTS ARE VARIABLE AND MUST BE INDIVIDUALIZED ON THE BASIS OF THE DISEASE UNDER TREATMENT AND THE RESPONSE OF THE PATIENT.
Multiple Sclerosis:
ADT (Alternative Day Therapy):















HOW SUPPLIED


4mg



8mg



16mg


32 mg


STORAGE AND HANDLING



PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Methylprednisolone

Methylprednisolone

Methylprednisolone

Methylprednisolone TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-969(NDC:59746-001)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
METHYLPREDNISOLONE methylprednisolone 4 mg

Inactive Ingredients

Ingredient Name Strength
SILICON DIOXIDE
ANHYDROUS LACTOSE
MAGNESIUM STEARATE
cellulose, microcrystalline
SODIUM LAURYL SULFATE
STARCH, CORN
SODIUM STARCH GLYCOLATE TYPE A POTATO

Product Characteristics

Color Size Imprint Code Shape
white 8 mm TL001 OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-969-05 21 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA040189 2012-07-10


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.